CAGRILINTIDE 10 mg

Cagrilintide 10mg is a state-of-the-art injectable peptide designed for weight loss and metabolic control. It was originally developed by the pharmaceutical company Novo Nordisk.

The 10mg presentation comes in the standard lyophilized (freeze-dried) powder format, which is primarily marketed for the research sector.

How does it work in the body?

Unlike medications such as Semaglutide (Ozempic/Wegovy), which mimic the GLP-1 hormone, Cagrilintide is an amylin analogue.

Satiety signal: It mimics the function of amylin, a hormone naturally released by the pancreas alongside insulin.

Brain effect: It acts directly on brain receptors that regulate appetite to reduce the urge to eat.

Gastric delay: It slows down stomach emptying, thereby prolonging the feeling of fullness.